{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:32:06Z","timestamp":1788474726105,"version":"build-2803163510"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Barth syndrome (BTHS) is a rare X-linked recessive genetic disease, which appears in infancy with myocardial and skeletal muscle diseases, neutropenia, growth retardation, and other clinical features. <jats:italic>TAFAZZIN<\/jats:italic> is the pathogenic gene of BTHS, which encodes the tafazzin protein of the inner membrane of the mitochondria, a phosphatidyltransferase involved in cardiolipin remodeling and functional maturation. At present, BTHS has been widely reported, but prenatal cases are rare. We report a 24<jats:sup>+4<\/jats:sup>-week fetus with clinical manifestations including left ventricular insufficiency and ascites. After induced labor, whole exome sequencing detection of fetal skin tissue showed that <jats:italic>TAFAZZIN<\/jats:italic> had the mutation c.311A\u2009&amp;gt;\u2009C\/<jats:italic>p<\/jats:italic>.His104Pro and that his mother was the carrier. This His104Pro mutation has hitherto not been reported, and it is rated as likely to be pathogenic according to the American College of Medical Genetics and Genetics guidelines. Molecular dynamics and protein expression experiments on the His104Pro mutation showed that the stability of the local protein structure and protein expression were reduced. In conclusion, the case presented in this study enriches our knowledge of the <jats:italic>TAFAZZIN<\/jats:italic> mutation spectrum and suggests that His104Pro may lead to cardiac structural abnormalities in the early embryo. The possibility of BTHS should be considered when an abnormal cardiac structure or ascites appear in a prenatal ultrasound.<\/jats:p>","DOI":"10.3389\/fped.2022.1004485","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:29:17Z","timestamp":1667978957000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Prenatal case report of Barth syndrome caused by novel TAFAZZIN mutation: Clinical characteristics of fetal dilated cardiomyopathy with ascites"],"prefix":"10.3389","volume":"10","author":[{"given":"Xuliang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-an","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510x(83)90209-5","article-title":"An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes","volume":"62","author":"Barth","year":"1983","journal-title":"J Neurol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ajmg.c.31372","article-title":"Barth syndrome","author":"Jefferies","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.bbalip.2012.11.007","article-title":"Cardiolipin remodeling and the function of tafazzin","volume":"1831","author":"Schlame","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1172-8-70","article-title":"Natural history of barth syndrome: a national cohort study of 22 patients","volume":"8","author":"Rigaud","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpeds.2019.09.074","article-title":"A Bayesian analysis to determine the prevalence of Barth syndrome in the pediatric population","volume":"217","author":"Miller","year":"2020","journal-title":"J Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1002\/ajmg.a.35609","article-title":"The Barth syndrome registry: distinguishing disease characteristics and growth data from a longitudinal study","author":"Roberts","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/(sici)1097-0223(199710)17:10%3C983::aid-pd174%3E3.0.co;2-0","article-title":"Prenatal clinical expression\u00a0of 3-methylglutaconic aciduria: Barth syndrome","volume":"17","author":"Cardonick","year":"1997","journal-title":"Prenat Diagn"},{"key":"B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/pd.1438","article-title":"X-linked fetal cardiomyopathy caused by a novel mutation in the TAZ gene","volume":"26","author":"Brady","year":"2006","journal-title":"Prenat Diagn"},{"key":"B11","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/pd.2599","article-title":"Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth","volume":"30","author":"Steward","year":"2010","journal-title":"Prenat Diagn"},{"key":"B12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/genes13040656","article-title":"Barth syndrome cardiomyopathy: an update","volume":"13","author":"Pang","year":"2022","journal-title":"Genes (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00018-008-8030-5","article-title":"Cardiolipin, the heart of mitochondrial metabolism","volume":"65","author":"Houtkooper","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"144148","DOI":"10.1016\/j.gene.2019.144148","article-title":"TAZ Encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome","volume":"726","author":"Garlid","year":"2020","journal-title":"Gene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymgme.2012.09.013","article-title":"Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle","volume":"107","author":"Ronvelia","year":"2012","journal-title":"Mol Genet Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1091\/mbc.e08-09-0896","article-title":"The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome","volume":"19","author":"Claypool","year":"2008","journal-title":"Mol Biol Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11745-016-4229-7","article-title":"Barth syndrome: connecting cardiolipin to cardiomyopathy","volume":"52","author":"Ikon","year":"2017","journal-title":"Lipids"},{"key":"B18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MOH.0b013e32835a01d9","article-title":"Haematological features in Barth syndrome","volume":"20","author":"Finsterer","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/bbrc.2000.3952","article-title":"Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome","volume":"279","author":"Vreken","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1399-3046.2006.00629.x","article-title":"Successful cardiac transplantation in Barth syndrome \u2013 single-centre experience of four patients","volume":"11","author":"Mangat","year":"2007","journal-title":"Pediatr Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/hum.2018.020","article-title":"AAV-mediated TAZ gene replacement restores mitochondrial and cardioskeletal function in Barth syndrome","volume":"30","author":"Suzuki-Hatano","year":"2019","journal-title":"Hum Gene Ther"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1004485\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T07:29:18Z","timestamp":1667978958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1004485\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":22,"alternative-id":["10.3389\/fped.2022.1004485"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1004485","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"article-number":"1004485"}}